Substance / Medication

Sodium iodide

Overview

Active Ingredient
sodium iodide
RxNorm CUI
9884

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

1 trials linked to this intervention

1
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of Oral Administration of Sodium Iodide to Prevent Bovine Respiratory Disease Complex.
Shoemake B M, Vander Ley B L, Newcomer B W et al. · J Vet Intern Med · 2018
PMID: 29377356RCTFull text (PMC)
Quantification of early adipose-derived stem cell survival: comparison between sodium iodide symporter and enhanced green fluorescence protein imaging.
Quach Cung Hoa Thien, Jung Kyung-Ho, Paik Jin-Young et al. · Nucl Med Biol · 2012
PMID: 22998839Observational
Effects of dose, intervention time, and radionuclide on sodium iodide symporter (NIS)-targeted radionuclide therapy.
Shen D H Y, Marsee D K, Schaap J et al. · Gene Ther · 2004
PMID: 14712300Observational
Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
Kang Joo Hyun, Chung June-Key, Lee Yong Jin et al. · J Nucl Med · 2004
PMID: 15347726Observational
Anion selectivity by the sodium iodide symporter.
Van Sande J, Massart C, Beauwens R et al. · Endocrinology · 2003
PMID: 12488351Observational
The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
Heltemes Lynn M, Hagan Christy R, Mitrofanova Elena E et al. · Cancer Gene Ther · 2003
PMID: 12489024Observational
Low expression of sodium iodide symporter identifies aggressive thyroid tumors.
Ward Laura S, Santarosa Patrícia L, Granja Fabiana et al. · Cancer Lett · 2003
PMID: 14550956Observational
Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
Keith C J, Miles K A, Griffiths M R et al. · Eur J Nucl Med Mol Imaging · 2002
PMID: 12173015Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sodium iodide (substance)
SNOMED CT
62754006
UMLS CUI
C0037521
RxNorm CUI
9884

Clinical Data

This intervention maps to 13 entities in the Healos knowledge graph.

8
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
1
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.